Showing results for:

MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)

- Results from the Phase 2 L-MIND study were highlighted as a late-breaking oral presentation at the American Association for Cancer Research Annual Meeting 2023BOSTON & WILMINGTON, Del.--(BUSINESS WIRE)--MorphoSys U.S. Inc., a fully owned subsidiary of MorphoSys AG (FSE:...

Guyana will be “gift that keeps on giving” – Analyst 

Guyana’s value to ExxonMobil will be felt for decades to come, according to an Analyst at Seeking Alpha, a crowd-sourced content service provider that publishes news on financial markets.  In his latest piece on April 12, the analyst examined Exxon’s...

Athersys Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX) today announced financial results for the three and 12 months ended December 31, 2022, and provided a business update. Fourth Quarter 2022 and Recent Corporate and Operational Highlights Largely completed the company’s restructuring initiative with the...

Role, capacity of environmental regulator critical to Guyana’s success with oil

Guyana’s Environmental Protection Agency (EPA) is a vital pillar in the country’s balancing act of being an oil producer, while also adhering to strict global climate goals.  And because of this, its institutional capacity must be strengthened to monitor and...

Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) Publish Ph3 Data Evaluating lebrikizumab Efficacy and Safety in...

Lebrikizumab is a novel monoclonal antibody that binds to IL-13 with high affinity and prevents its downstream signaling with high potency The NEJM manuscript reports Week 16 efficacy and safety data from ADvocate1 and ADvocate2, two identically designed Phase 3...

Poxel Announces Cash Runway Extended Through Q2 2025 Based upon Debt Restructuring Agreement and New Equity-linked Financing Facility

Restructuring of the Company’s debt postpones initiation of repayments to Q1 2025, to be repaid with positive net royalty1 flow to Poxel anticipated to start in Sumitomo Pharma’s FY20242 based on the strong growth trajectory of TWYMEEG® (Imeglimin) sales New...

New Four-Year Data for Genentech’s Evrysdi Reinforce Long-Term Efficacy and Safety Profile in Some of the Most Severely Affected People With Types 2 and...

– Data from pivotal SUNFISH study showed increases in motor function observed during the first year were maintained through the fourth year, while the overall rate of adverse events continued to decrease – – Data confirm long-term efficacy and safety...

Exxon mulling dumping stakes in Italy’s main regasification terminal

Keeping to its strategy to divest from non-core assets, ExxonMobil is mulling selling off its majority stake in Italy’s main regasification terminal - Rovigo LNG.  Also called Adriatic LNG, the terminal is owned by ExxonMobil Italiana Gas S.r.l. which holds...

New Guyana oil contracts looking to set stricter path to final investment decisions

With Guyana’s draft model petroleum agreements now in the public domain, it is clear that the government is seeking to encourage international oil companies (IOCs) to commit to development of commercial discoveries in a timely manner. The contract effectively...

Transgene to Present Multiple Posters Highlighting the Potential of its Exciting Immunotherapy Pipeline at AACR 2023

New Phase I data confirm high immunogenicity and promising efficacy profile of TG4050, an individualized neoantigen cancer vaccine developed by Transgene in collaboration with NEC Corporation Exciting preclinical data on the novel IV oncolytic virus candidate TG6050 STRASBOURG, France--(BUSINESS WIRE)--#HBV--Regulatory News: Transgene...

Latest News

Guyana and Suriname leaders advance talks on trade, energy, and connectivity at high-level meeting

Joint Statement - Meeting Between Jennifer Geerlings- Simons, President of the Republic of Suriname and Dr. Mohamed Irfaan Ali,...